They suggested that PPP2R1A acted as a downstream effector in hepatoma, mitigating the enhanced cell migration driven by WNK1, a key protein kinase involved in tumor-induced angiogenesis. This evidence concerns the gene PPP2R1A and hepatocellular carcinoma.